INS and obstructive sleep apnea syndrome: Despite the methodological challenges hampering in vitro hypoxic studies [9], independent groups have reported using intermittent hypoxia (mimicking the oxygen desaturations present in OSA patients) to reduce insulin signaling in hepatocytes [10] and adipocytes [11], which leads to reduced glucose uptake and augmented lipolysis [12].